Enhancing the Effectiveness of Physical Therapy for People With Knee Osteoarthritis
22 juin 2015 mis à jour par: g. kelly fitzgerald, Agency for Healthcare Research and Quality (AHRQ)
Enhancing the Effectiveness of Physical Therapy for People With Knee
The overall aim of the project is to examine the clinical and cost-effectiveness of utilizing booster sessions(periodic face-to-face follow-up appointments that take place several weeks or months following discharge from the supervised therapy program designed to review the patient's current rehabilitation program, troubleshoot any problems with the program, and make recommendations for program progression or modification) in the delivery of exercise therapy, and supplementing exercise therapy with manual therapy techniques(manually applied treatment techniques such as joint mobilization/manipulation, manual traction, soft tissue manipulations, passive stretching and range of motion).
The investigators will do this in a randomized, multi-center, clinical trial.
The investigators hypothesize that adding manual therapy techniques will be more clinically effective than exercise alone and that using booster sessions will maintain longer term clinical effects and be more cost-effective than not using booster sessions.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
Exercise therapy (ET) is effective as the first line of treatment for reducing pain and disability in patients with knee osteoarthritis (OA), but studies show its effects diminish considerably over time.
'Booster' intervention sessions (periodic face-to-face follow-up appointments following discharge from supervised therapy designed to review and progress the patient's home program, troubleshoot problems with the program, etc.) have been recommended to make beneficial effects endure however this recommendation has not been adequately tested.
There are also indications that manual therapy (MT), manually applied treatment techniques such as joint mobilization/manipulation, manual traction, soft tissue manipulations, and passive stretching, when combined with ET, may improve the overall effectiveness of rehabilitation for reducing pain and disability, and, may significantly delay or reduce the need for total knee arthroplastic surgery and reduce medication intake in people with knee OA.
However, current published evidence-based treatment guidelines indicate there is not enough data to make a definitive recommendation regarding the use of MT with ET in rehabilitation programs.
Therefore, the overall aim of the project is to examine the clinical and cost-effectiveness of utilizing booster sessions in the delivery of ET, and supplementing ET with MT techniques.The study will be a multi-center,randomized clinical trial, using a 2 x 2 factorial design (factor 1 = booster vs no booster, factor 2 = ET alone vs ET + MT).
Three hundred subjects (100 per study site) with knee OA will be randomized to one of the following groups: 1) ET - no booster, 2) ET - with booster, 3) MT + ET - no booster sessions, 4) MT + ET - with booster sessions.
Clinical outcome measures (WOMAC, knee pain, global rating of change and performance-based measures of function) will be taken at baseline (prior to randomization), at the completion of the initial therapy sessions (9 weeks) and at 1 year follow-up.
The primary endpoint for clinical outcome will be the WOMAC at 1 year.For the cost effectiveness analysis, the primary cost outcome will be osteoarthritis treatment costs from the societal perspective, which will include health system costs for implementing each intervention, medical/surgical costs (primary, secondary, and tertiary care costs), and personal costs to participants (travel, non-funded medications, time off work, and quality-of-life burdens).
The primary effectiveness outcome measure will be quality-adjusted life-years (QALYs), derived using quality of life utilities from EQ-5D scores.
Cost and effectiveness values between interventions will be compared via incremental cost-effectiveness ratios, yielding incremental costs per QALY gained when a given intervention is chosen.
Secondary analyses will examine cost-effectiveness from health system and from patient perspectives.
Cost and effectiveness data will be obtained at 1 year and 2 year follow-ups.
The 2 year follow-up will be the primary endpoint for the cost-effectiveness analysis.
Type d'étude
Interventionnel
Inscription (Réel)
300
Phase
- Phase 2
- Phase 3
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, États-Unis, 15260
- University of Pittsburgh
-
-
Texas
-
San Antonio, Texas, États-Unis
- Army-Baylor University
-
-
Utah
-
Salt Lake City, Utah, États-Unis
- Intermountain Healthcare
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
40 ans et plus (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
- 40 years of age or older
- Meet the American College of Rheumatology (ACR) clinical criteria for a diagnosis of knee OA. The ACR clinical criteria for knee OA includes knee pain plus 3 of the following 6 criteria:
- age > 50 years,
- morning stiffness of < 30 minutes,
- crepitus on active movement,
- tenderness of the bony margins of the joint,
- bony enlargement of the joint noted on exam,
- lack of palpable warmth of the synovium. Based on this criteria, a subject who is less than 50 years but has knee pain and 3 of the other 5 criteria would also be classified as having knee OA.
Exclusion Criteria:
- do not meet the ACR clinical criteria for knee OA,
- are scheduled for total knee arthroplasty (TKA) surgery,
- have undergone TJA surgery on any lower extremity joint,
- exhibit uncontrolled hypertension (i.e. individuals not currently taking medication for hypertension whose systolic blood pressure is greater than 140 mm Hg or diastolic blood pressure greater than 90 mm Hg at rest),
- have complaints of low back pain or other lower extremity joint pain that affects function at the time of recruitment,
- have a history of neurological disorders that would affect lower extremity function (stroke, peripheral neuropathy, parkinson's disease, multiple sclerosis, etc.),
- are women who are pregnant.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation factorielle
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: exercise
Subjects in this arm receive 12 exercise sessions in 9 weeks.
|
The program starts with a 10 minute aerobic exercise warm-up (treadmill walking or stationary cycling).
Subjects then perform a series of strengthening, stretching, and neuromuscular control activities which are core exercises for the program and mandatory.
In addition to the above core exercises, therapists have the option to select additional optional exercise activities, based on the initial examination findings.
These exercises will address strength or flexibility in the hip, and ankle if impairments are identified in the initial examination.
|
|
Comparateur actif: exercise + manual therapy
Subjects in this group receive exercise combined with manual therapy techniques for 12 sessions in 9 weeks.
|
The program starts with a 10 minute aerobic exercise warm-up (treadmill walking or stationary cycling).
Subjects then perform a series of strengthening, stretching, and neuromuscular control activities which are core exercises for the program and mandatory.
In addition to the above core exercises, therapists have the option to select additional optional exercise activities, based on the initial examination findings.
These exercises will address strength or flexibility in the hip, and ankle if impairments are identified in the initial examination.
The manual therapy (MT)techniques are maneuvers that are applied with manual force from the treating therapist.
The MT techniques will include a series of accessory motion techniques, manual stretching , and soft tissue manipulation (deep massage to muscles and connective tissues associated with knee function).
Core techniques include anterior-posterior and posterior-anterior tibiofemoral translations, superior-inferior and medial-lateral patellofemoral mobilizations, knee flexion and extension mobilizations that may be combined with varus-valgus stresses,medial-lateral tibial rotations, manual stretching of the quadriceps, rectus femoris, hamstring, and gastrocnemius muscles, and soft tissue manipulations of the quadriceps, peri-patellar tissues, hamstring, hip adductors, and gastroc-soleus muscle groups.
There are optional MT techniques for the hip, and foot and ankle joints that can be selected by the therapist based on initial examination findings.
|
|
Expérimental: exercise + booster
subjects in this arm will receive exercise sessions delivered with booster sessions (8 sessions in the first 9 weeks, 2 sessions at 5 months, 1 session at 8 months, and 1 session at 11 months).
|
The program starts with a 10 minute aerobic exercise warm-up (treadmill walking or stationary cycling).
Subjects then perform a series of strengthening, stretching, and neuromuscular control activities which are core exercises for the program and mandatory.
In addition to the above core exercises, therapists have the option to select additional optional exercise activities, based on the initial examination findings.
These exercises will address strength or flexibility in the hip, and ankle if impairments are identified in the initial examination.
|
|
Expérimental: exercise + manual therapy + booster
Subjects in this arm will receive exercise combined with manual therapy techniques and booster sessions.
|
The program starts with a 10 minute aerobic exercise warm-up (treadmill walking or stationary cycling).
Subjects then perform a series of strengthening, stretching, and neuromuscular control activities which are core exercises for the program and mandatory.
In addition to the above core exercises, therapists have the option to select additional optional exercise activities, based on the initial examination findings.
These exercises will address strength or flexibility in the hip, and ankle if impairments are identified in the initial examination.
The manual therapy (MT)techniques are maneuvers that are applied with manual force from the treating therapist.
The MT techniques will include a series of accessory motion techniques, manual stretching , and soft tissue manipulation (deep massage to muscles and connective tissues associated with knee function).
Core techniques include anterior-posterior and posterior-anterior tibiofemoral translations, superior-inferior and medial-lateral patellofemoral mobilizations, knee flexion and extension mobilizations that may be combined with varus-valgus stresses,medial-lateral tibial rotations, manual stretching of the quadriceps, rectus femoris, hamstring, and gastrocnemius muscles, and soft tissue manipulations of the quadriceps, peri-patellar tissues, hamstring, hip adductors, and gastroc-soleus muscle groups.
There are optional MT techniques for the hip, and foot and ankle joints that can be selected by the therapist based on initial examination findings.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Western Ontario and McMaster University Osteoarthritis Index (WOMAC)
Délai: Change from baseline at 9 weeks, 1 year and 2 years
|
Self report measure of pain, stiffness, and physical function for people with knee osteoarthritis.
|
Change from baseline at 9 weeks, 1 year and 2 years
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Cost/Utility Ratio
Délai: 2 years
|
In the analysis, the effectiveness term will be quality adjusted life years, which is the product of the quality of life utility associated with a health state and the length of time lived in that state, summed over time.
Utilities are a measure of preference for a health state and range from 0 (death) to 1 (perfect health).
In this analysis, utilities will be derived from EQ-5D scores.
The cost-effectiveness ratio (or, in this analysis, the cost-utility ratio) is the difference in cost divided by the difference in quality-adjusted life-years between intervention groups.
|
2 years
|
|
Change in Numeric Knee Pain Rating Scale
Délai: Change from Baseline to 9 weeks, 1 and 2 years
|
Subjects will rate their worst knee pain in the last 24 hours using an 11 point numeric pain rating scale with 0 representing "no pain" and 10 representing " the worst pain imaginable."
|
Change from Baseline to 9 weeks, 1 and 2 years
|
|
Global Rating of Change
Délai: Change from baseline to 9 weeks, 1 and 2 years
|
The global rating of change is a 15 item scale in which subjects will rate the degree to which their knee condition has changed from the time treatment was initiated to the present.24
The subject responds to the following query: "Please rate your overall knee's condition from the time you began treatment until now (check only one)."
The items range from "A very great deal better" to "A very great deal worse."
|
Change from baseline to 9 weeks, 1 and 2 years
|
|
Change in Timed Up and Go Test Time
Délai: Change from Baseline to 9 weeks and 1 year
|
On the command "go" subjects will stand up from a chair, walk 3 meters, turn around, return to the chair and sit down.
The time it takes to complete this task will be recorded.
|
Change from Baseline to 9 weeks and 1 year
|
|
Change in 30 second time chair rise test.
Délai: Change from Baseline to , 9 weeks, 1 year
|
Subjects will be seated with their arms crossed in front of their chest.
On the command "go" subjects will stand up and sit down for as many trials as they can in a 30 second period.
|
Change from Baseline to , 9 weeks, 1 year
|
|
Change in Self-paced Walk Test Time
Délai: Change from Baseline to 9 weeks, 1 year
|
Subjects will walk 4 lengths of a 10 meter indoor course in response to the instructions, "Walk as quickly as you can without overexerting yourself."
|
Change from Baseline to 9 weeks, 1 year
|
|
Change in Pain belief screening instrument
Délai: Change in Baseline to 1 year
|
7 item instrument that queries the subject about their pain and how they believe pain limits or does not limit their ability to perform daily activities, social and liesure interactions, mood, etc.
|
Change in Baseline to 1 year
|
|
Change in Beck Anxiety Index (BAI)
Délai: Change from Baseline to 1 year
|
The BAI consists of 21 items, each item scored 0-3, with higher scores representing higher levels of anxiety.
|
Change from Baseline to 1 year
|
|
Change in Center for Epidemiological Studies Depression Scale (CES-D)
Délai: Change from Baseline to 1year
|
The CES-D is a 20-item self-report depression scale, each item scored 0-3, with higher scores representing greater symptoms of depression.
|
Change from Baseline to 1year
|
|
Change in EQ-5D
Délai: Change from Baseline to 1 and 2 years
|
The EQ-5D is a generic health-related quality of life measure.
The EQ-5D consists of the following five dimensions: 1) Mobility, 2) Self-care, 3) Usual activities, 4) Pain/discomfort, and 5) Anxiety/depression (AD).Each dimension has three possible levels (i.e., 1, 2, or 3), representing "no problems," "some problems," and "extreme problems," respectively.
Respondents are asked to choose one level that reflects their "own health state today" for each of the five dimensions.
|
Change from Baseline to 1 and 2 years
|
|
OARSI Responder Criteria
Délai: 9 weeks and 1 year
|
Responder criteria included 1) greater than or equal to 50% improvement in WOMAC pain or WOMAC function and an absolute improvement of greater than or equal to 20, or 2) improvement in at least 2 of the following 3 scores: 20% improvement in pain and absolute change ≥ 10 on WOMAC pain score, 20% improvement in pain and absolute change ≥ 10 on WOMAC function score, or moderate or greater improvement (≤ 4) on a 15 point global rating of change scale.
|
9 weeks and 1 year
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Les enquêteurs
- Chercheur principal: G. Kelley Fitzgerald, PT, PhD, University of Pittsburgh
- Chercheur principal: Julie M Fritz, PT, PhD, Intermountain Healthcare, Salt Lake City, UT
- Chercheur principal: John D Childs, PT, PhD, Army-Baylor University, San Antonio, TX
- Chercheur principal: J. Haxby Abbott, PT, PhD, University of Otago, Dunedin, New Zealand
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Publications générales
- Bove AM, Smith KJ, Bise CG, Fritz JM, Childs JD, Brennan GP, Abbott JH, Fitzgerald GK. Exercise, Manual Therapy, and Booster Sessions in Knee Osteoarthritis: Cost-Effectiveness Analysis From a Multicenter Randomized Controlled Trial. Phys Ther. 2018 Jan 1;98(1):16-27. doi: 10.1093/ptj/pzx104.
- Fitzgerald GK, Fritz JM, Childs JD, Brennan GP, Talisa V, Gil AB, Neilson BD, Abbott JH. Exercise, manual therapy, and use of booster sessions in physical therapy for knee osteoarthritis: a multi-center, factorial randomized clinical trial. Osteoarthritis Cartilage. 2016 Aug;24(8):1340-9. doi: 10.1016/j.joca.2016.03.001. Epub 2016 Mar 10.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude
1 avril 2011
Achèvement primaire (Réel)
1 avril 2015
Achèvement de l'étude (Réel)
1 avril 2015
Dates d'inscription aux études
Première soumission
23 février 2011
Première soumission répondant aux critères de contrôle qualité
11 mars 2011
Première publication (Estimation)
14 mars 2011
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
23 juin 2015
Dernière mise à jour soumise répondant aux critères de contrôle qualité
22 juin 2015
Dernière vérification
1 juin 2015
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 1R01HS019624-01 (Subvention/contrat AHRQ des États-Unis)
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .